Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Blank Check IPOs (SPACS) -- Ignore unavailable to you. Want to Upgrade?

To: Rollcast... who wrote (1157)	8/28/2007 10:21:58 AM
From: Glenn Petersen	Read Replies (2) \| Respond to of 3862

The court has affirmed the validity of the PIP merger (though it is still subject to an appearl for 30 days). I closed out my warrant position this morning. Delaware Court of Chancery Determines Validity of PharmAthene Merger Tuesday August 28, 8:30 am ET ANNAPOLIS, Md., Aug. 28 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (AMEX: PIP - News) announced today that, in connection with the previously announced proceedings initiated in Delaware Chancery Court, the Court determined yesterday that the merger between PharmAthene and Healthcare Acquisition Corp. had been validly approved and authorized in full compliance with the Company's charter and Delaware corporate law. As is generally the case with decisions of the Court of Chancery, this decision will be subject to appeal for 30 days in accordance with Delaware law. <snip> biz.yahoo.com